The Global Burden of Cardiovascular Disease

Cardiovascular disease (CVD) today is responsible for approximately one-third of deaths worldwide, and that figure will surely increase in both developing and developed countries as risk factors for the disease--primarily dyslipidemia, hypertension, obesity, diabetes, physical inactivity, poor diet, and smoking--continue to increase. Although these risk factors are modifiable, to date there is a relative paucity of measures to prevent or control them, particularly in developing countries. A population strategy combined with a high-risk strategy for CVD prevention could greatly reduce the burden of disease in the coming decades. Many initiatives are working, but many more are needed. This chapter provides background on the global burden of CVD and provides the context for the subsequent chapters addressing nurses' roles in reversing the bleak predictions for the ravages of CVD if risk factors are left unchecked in the coming decades.

[1]  G. E. Who,et al.  Preventing chronic diseases: a vital investment , 2005 .

[2]  A. Folsom,et al.  Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. , 1998, The New England journal of medicine.

[3]  S. Yusuf,et al.  Education and risk for acute myocardial infarction in 52 high, middle and low-income countries: INTERHEART case-control study , 2009, Heart.

[4]  R. Fagard Prescription and Results of Physical Activity , 1995, Journal of cardiovascular pharmacology.

[5]  B. Popkin The nutrition transition in low-income countries: an emerging crisis. , 2009, Nutrition reviews.

[6]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[7]  Reddy Ks,et al.  Cardiovascular diseases in India. , 1993, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[8]  Simon Capewell,et al.  Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. , 2007, Journal of the American College of Cardiology.

[9]  S. Yusuf,et al.  Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. , 2001, Circulation.

[10]  Alan D. Lopez,et al.  The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .

[11]  L. Goldman,et al.  Adolescent overweight and future adult coronary heart disease. , 2007, The New England journal of medicine.

[12]  S. Friel,et al.  Unequal weight: equity oriented policy responses to the global obesity epidemic , 2007, BMJ : British Medical Journal.

[13]  W. Maziak,et al.  Tobacco smoking using a waterpipe: a re-emerging strain in a global epidemic , 2004, Tobacco Control.

[14]  A. Drewnowski,et al.  The nutrition transition: new trends in the global diet. , 2009, Nutrition reviews.

[15]  K. Kotseva,et al.  Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries , 2009, The Lancet.

[16]  Alan D. Lopez,et al.  Measuring the global burden of disease and epidemiological transitions: 2002–2030 , 2006, Annals of tropical medicine and parasitology.

[17]  H. Westley Thin living , 2007, BMJ : British Medical Journal.

[18]  E. Breeze,et al.  Life expectancy in relation to cardiovascular risk factors: 38 year follow-up of 19 000 men in the Whitehall study , 2009, BMJ : British Medical Journal.

[19]  G. Rose,et al.  Alcohol and Drugs: the Scottish Experience , 1993 .

[20]  K. Pyörälä,et al.  Cardiovascular risk prediction systems have to be adapted and updated to current national conditions , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[21]  Shah Ebrahim,et al.  Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) , 2007 .

[22]  W. Maziak,et al.  Prevalence and characteristics of narghile smoking among university students in Syria. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[23]  H. Boshuizen,et al.  Effect Size Estimates of Lifestyle and Dietary Changes on All-Cause Mortality in Coronary Artery Disease Patients: A Systematic Review , 2005, Circulation.

[24]  R. Watson Steps to a leaner Europe , 2007, BMJ : British Medical Journal.

[25]  T. Gaziano Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa , 2008, Heart.

[26]  D. Stewart,et al.  Cardiac rehabilitation II: referral and participation. , 2002, General hospital psychiatry.

[27]  Policy Dialogue,et al.  Women and Health: Today's Evidence, Tomorrow's Agenda , 2010 .

[28]  W. Muna Cardiovascular disorders in Africa. , 1993, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[29]  S. Tonstad,et al.  Effect of dietary and antismoking advice on the incidence of myocardial infarction: a 16-year follow-up of the Oslo Diet and Antismoking Study after its close. , 2006, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[30]  Alan D. Lopez,et al.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.

[31]  Zhi-quan Liu Dietary sodium and the incidence of hypertension in the Chinese population: a review of nationwide surveys. , 2009, American journal of hypertension.

[32]  J. Critchley,et al.  Explaining the Increase in Coronary Heart Disease Mortality in Beijing Between 1984 and 1999 , 2004, Circulation.

[33]  K. Reynolds,et al.  Global burden of hypertension: analysis of worldwide data , 2005, The Lancet.

[34]  J. Critchley,et al.  Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000. , 2005, American journal of public health.

[35]  W. Maziak,et al.  Patterns of waterpipe use and dependence: implications for intervention development , 2005, Pharmacology Biochemistry and Behavior.

[36]  Sonia S. Anand,et al.  Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. , 2008, European heart journal.

[37]  H. Tunstall-Pedoe,et al.  Contribution of trends in survival and coronar y-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations , 1999, The Lancet.

[38]  T. Sørensen,et al.  [Childhood body mass index and the risk of coronary heart disease in adulthood]. , 2007, Ugeskrift for laeger.

[39]  R. Gupta,et al.  Trends in hypertension epidemiology in India , 2004, Journal of Human Hypertension.

[40]  A. Alwan Cardiovascular diseases in the eastern Mediterranean region. , 1993, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[41]  J. McMurray,et al.  Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994 , 1999, Heart.

[42]  Alan Shihadeh,et al.  Polycyclic aromatic hydrocarbons, carbon monoxide, "tar", and nicotine in the mainstream smoke aerosol of the narghile water pipe. , 2005, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[43]  M. Eisenberg,et al.  Coronary artery disease in the developing world. , 2004, American heart journal.

[44]  S. Ebrahim,et al.  Multiple risk factor interventions for primary prevention of coronary heart disease. , 2011, The Cochrane database of systematic reviews.

[45]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[46]  S. Yusuf,et al.  Prevalence of cardiovascular risk factors in the Middle East: a systematic review , 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[47]  George A. Mensah,et al.  The atlas of heart disease and stroke , 2005 .

[48]  E. Ford,et al.  Coronary heart disease trends in England and Wales from 1984 to 2004: concealed levelling of mortality rates among young adults , 2007, Heart.

[49]  R. D'Agostino,et al.  Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality. The Framingham Heart Study 1950 to 1990. , 1996, Circulation.

[50]  K. Kotseva,et al.  Should cardiovascular disease prevention be undertaken by doctors or policymakers and politicians , 2009 .

[51]  Murilo Foppa,et al.  Impacto econômico dos casos de doença cardiovascular grave no Brasil: uma estimativa baseada em dados secundários , 2008 .

[52]  J. Murín,et al.  Should cardiovascular disease prevention be undertaken by national cardiac societies , 2009 .

[53]  James F Sallis,et al.  AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. , 2002, Circulation.

[54]  V. Salomaa,et al.  Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. , 2005, American journal of epidemiology.

[55]  D. Lawlor,et al.  Treatment and prevention of obesity--are there critical periods for intervention? , 2006, International journal of epidemiology.

[56]  Rajeev Gupta,et al.  Younger age of escalation of cardiovascular risk factors in Asian Indian subjects. , 2009 .

[57]  N. Miller,et al.  Cardiovascular disease prevention and disease management: A critical role for nursing. , 2006, Journal of cardiopulmonary rehabilitation.

[58]  S. Yusuf,et al.  Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. , 2001, Circulation.

[59]  Rafael Emidio da Silva,et al.  Viable myocardium scintigraphy with intravenous nitroglycerine by computed tomography with Tc-99m (MIBI). , 2008, Arquivos brasileiros de cardiologia.

[60]  M. Peden,et al.  Tackling cardiovascular disease in Africa , 2005, BMJ : British Medical Journal.

[61]  A. Omran The epidemiologic transition. A theory of the epidemiology of population change. , 1971, The Milbank Memorial Fund quarterly.